Home › Funds › Bellevue Group AG › RMD

Bellevue Group AG position in RMD

RESMED INC · Health Care

Bellevue Group AG reported holding 148,195 shares of RMD (RESMED INC) in its Q2 2026 13F filing — a position valued at US$28.9M, representing 0.61% of its reported portfolio and ranking #39 among its reported holdings. Bellevue Group AG has disclosed RMD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)148.19K sh
Reported value held$28.88M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Bellevue Group AG's RMD position evolved

Bellevue Group AG first disclosed a stake in RMD in Q3 2023 at 76,696 shares (US$11.3M). The position peaked in Q3 2025 at 164,834 shares, worth US$45.1M. Across 12 filings, Bellevue Group AG increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 148,195 shares valued at US$28.9M — a reduction of -11,151 shares quarter over quarter.. Notable position changes include a 60% trim in Q4 2023 (shares rose 15% over the following quarter), a 413% increase in Q2 2024 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 76.70K $11.34M New
Q4 2023 30.32K $5.22M Reduce
Q1 2024 30.39K $6.02M Hold
Q2 2024 155.88K $29.84M Add
Q3 2024 160.13K $39.09M Add
Q4 2024 160.79K $36.77M Hold
Q1 2025 165.80K $37.11M Add
Q2 2025 165.80K $42.78M Hold
Q3 2025 164.83K $45.12M Reduce
Q4 2025 161.21K $38.83M Reduce
Q1 2026 159.35K $35.77M Reduce
Q2 2026 148.19K $28.88M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RMD and 13F data

RMD (RESMED INC) is a Health Care company. 32 other funds we track also report a position in RMD. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RMD

No other tracked fund reports a position in RMD.

All RMD fund holders →

FAQ

How long has Bellevue Group AG held RMD?

Bellevue Group AG has disclosed RMD holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is Bellevue Group AG's current position in RMD?

As of Q2 2026, Bellevue Group AG holds 148.19K shares of RMD (RESMED INC), valued at $28.88M, representing 0.61% of its reported portfolio and ranking #39.

Has Bellevue Group AG been buying or selling RMD?

In the latest 13F filing (Q2 2026), Bellevue Group AG reduced its position in RMD. The position peaked in Q3 2025 at 164.83K shares.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.